You are the owner of this page.
Edit Page
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Direxion S&P Biotech Bull 3X (NY: LABU)
41.40 USD  +1.59 (+3.99%)
Official Closing Price  /  Updated: 8:00 PM EST, Nov 15, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Direxion S&P Biotech Bull 3X
Sector
Exchange Traded NY
Net Assets 178.50M
Inception Date
Related Funds
Quote
Price 41.40
Volume 1,317,300
Last Trade Nov 15, 8:00pm
Change (%)
+1.59 (3.99%)
Prev. Close 39.81
YTD %
+21.12%
Dividend Yield 0.28%
Performance
YTD
+7.22 (21.12%)
1 Month
+6.65 (19.14%)
3 Month
-0.20 (-0.48%)
6 Month
+0.88 (2.17%)
1 Year
-6.85 (-14.20%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Sell on the Pop Prospects: November 13 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Sell on the Pop Prospects: September 18 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Top News
More News
First Week of September 20th Options Trading For Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU)
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading this week, for the September 20th expiration. At Stock Options... Read More
from Market News Video
These Are The Leveraged ETFs At Play When Trade War Worries Strike
The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put ... Read More
from Benzinga
Sell on the Pop Prospects: July 24 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Trading Eye For The Rate-Cut Guy
If monetary policy hawks were hoping to get a reprieve from the rising sentiment of an upcoming rate cut, Jerome Powell’s ... Read More
from Benzinga
Sell on the Pop Prospects: June 26 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
A Beloved Biotech ETF Could Lure Traders Again
With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has gone from less... Read More
from ETF Trends
It's Time To Consider Leveraged Healthcare ETFs
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven... Read More
from Blogs - TalkMarkets
It's Time To Consider Leveraged Healthcare ETFs
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
By Direxion One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has... Read More
from ETFdb
5 Leveraged ETFs With Biggest 1-Month Fund Flows
For the past month, leveraged exchange-traded fund (ETF) traders have been feasting off opportunities in gold, biotech, large caps, and semiconductors as the U.S.-China trade deal went awry. The flight... Read More
from ETF Trends
Stock ETFs Outpace Bond ETF Interest By $18B April
Equity markets have been on a tear since the beginning of the year, and ETFs are reflecting this trend, with Equity ETF inflows outpacing bond ETFs by $18 billion in April alone. While many have... Read More
from ETF Trends
5 Best-Performing Leveraged ETFs Year-to-Date
As the first quarter of 2019 drew to a close, leveraged ETF traders saw oil and technology take the top spots for year-to-date gainers. 2019 started off strong for U.S. equities–the Dow Jones... Read More
from ETFdb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.